Sector area index: a novel supporting marker for blepharoptosis screening and grading
International Ophthalmology · 01.11.2023 · 43 (12) · 4967-4978
DOI: 10.1007/s10792-023-02899-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, online erschienen am 01.11.2023. Verfasst von Tahereh Mahmoudi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics and Biomedical Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Blepharoptosis, Blepharoplasty. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To introduce a new supporting marker for discriminating different grades of ptosis called Sector Area Index (SAI) and a semi-automated technique to calculate it. METHODS: In this cross-sectional comparative case series, a circle enclosing the intercanthal distance was automatically drawn after choosing two points as the medial and lateral canthus and manually selecting the palpebral fissure region. Finally, 15-degree apart sectors are applied to the enclosed circle. SAI was measured automatically by dividing the area of each 15-degree sector marked with the upper eyelid contour by the total area of the sector marked with the edge of the surrounding circle. SAI values and inter-eye SAI differences were compared between patients with different grades of ptosis as well as normal patients. RESULTS: In the current study, 106 eyes were recruited (30, 25, 27, and 24 in the control, mild, moderate, and severe ptosis groups, respectively). Mean values of SAI in all sectors showed a decreasing trend from normal individuals toward patients with severe ptosis. The mean difference values of SAI between study eyes and fellow eyes in all four groups of patients showed a statistically significant difference (p < 0.05). In a pairwise comparison between groups, mean values of SAI in all nasal sectors from 15° to 60° showed a statistically significant difference between all groups (p < 0.05). CONCLUSION: The mean difference of SAI between study eyes and fellow eyes, including eyelid curvature, especially in 15°-60° and 120°-165° sectors, can demonstrate differentiating performance for detecting and discriminating varying grades of ptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics and Biomedical Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Medical Physics and Biomedical Engineering, Sciences and Advanced Medical Technologies and Equipment Institute (AMTEI), Tehran University of Medical, Tehran, Iran.
- Department of Biostatistics and Epidemiology, Tehran University of Medical Sciences, Tehran, Iran.
- Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Mahmoudi, T., Riazi-Esfahani, H., Montazeriani, Z., Yaseri, M., Mehdipour Namdar, Z., Jamali, M., Rafizadeh, S. M., & Khalili Pour, E. (2023). Sector area index: a novel supporting marker for blepharoptosis screening and grading. International Ophthalmology, 43(12), 4967-4978. https://doi.org/10.1007/s10792-023-02899-5
Vancouver
Mahmoudi T, Riazi-Esfahani H, Montazeriani Z, Yaseri M, Mehdipour Namdar Z, Jamali M, et al. Sector area index: a novel supporting marker for blepharoptosis screening and grading. International Ophthalmology. 2023;43(12):4967-4978. doi:10.1007/s10792-023-02899-5
BibTeX
@article{Mahmoudi2023,
author = {Mahmoudi, Tahereh and Riazi-Esfahani, Hamid and Montazeriani, Zahra and Yaseri, Mehdi and Mehdipour Namdar, Zahra and Jamali, Mohsen and Rafizadeh, Seyed Mohsen and Khalili Pour, Elias},
title = {Sector area index: a novel supporting marker for blepharoptosis screening and grading},
journal = {International Ophthalmology},
year = {2023},
volume = {43},
number = {12},
pages = {4967--4978},
doi = {10.1007/s10792-023-02899-5}
}
EUVIMED